A rapid method for purification of monoclonal human IgM from mass culture

H P Vollmers1, E Wozniak, E Stepien-Bötsch

  • 1Institut für Pathologie, Universität Würzburg, Germany.

Human Antibodies and Hybridomas
|January 1, 1996
PubMed

Insights

This study presents a fast and affordable method for purifying human immunoglobulin M (IgM) from hybridoma cultures. The technique yields over 14 mg of high-quality IgM within 6 hours, suitable for various applications.

Area of Science:

  • Immunology
  • Biochemistry
  • Biotechnology

Background:

  • Hybridoma technology is crucial for monoclonal antibody production.
  • Purification of immunoglobulin M (IgM) from hybridoma supernatant is essential for research and diagnostics.
  • Existing IgM purification methods can be time-consuming and expensive.

Purpose of the Study:

  • To develop a rapid, cost-effective, and selective method for human IgM purification.
  • To optimize IgM purification from large-scale hybridoma cultures.
  • To ensure the functional integrity of purified IgM for physiological and immunohistochemical applications.

Main Methods:

  • Hybridomas were cultured in RPMI media with 10% fetal calf serum (FCS).
  • Supernatant concentration was achieved via ultrafiltration.
  • Purification involved dialysis against distilled water at pH 6.4.

Main Results:

  • Over 14 mg of human IgM was purified from 5 liters of hybridoma supernatant.
  • The purification process was completed within 6 hours.
  • The majority of purified IgM retained its pentameric and monomeric forms.
  • Purified IgM demonstrated positive results in physiological and immunohistochemical studies.

Conclusions:

  • The described two-step method offers a rapid and economical approach for human IgM purification.
  • This technique is suitable for large-scale hybridoma supernatant processing.
  • The purified IgM maintains its structural integrity and biological activity, making it valuable for research and clinical use.